Home » Newsletters » BioWorld Science

BioWorld Science

June 9, 1999

View Archived Issues

HAV vaccine prevents secondary hepatitis A infection

ACE gene insertion/deletion polymorphism: therapeutic implications for ACE inhibitor therapy

Fluvastatin associated with beneficial effects in CAD patients with low HDL cholesterol levels

Company Profile: Northwest Biotherapeutics

A novel antiarrhythmic mechanism explored

Valaciclovir reduces CMV in kidney transplant recipients

Novel marine metabolite has antiinflammatory properties

Novel antitumor agents from Minophagen with an imidazo[1,5-a]pyrimidine structure

DiagnoCure extends agreement with Organon Teknika to all cancers

New use for an old drug: doxycycline in the treatment of abdominal aortic aneurysms

Unimed in discussions to sell stock

GlycoDesign seeks partners to advance the development of GlcNAc-TV enzyme inhibitors

Academic researchers move closer to the development of an artificial pancreas

Phase III study supports efficacy and safety of Hextend in treatment of hypovolemia

FDA approves IND for Adolor's novel analgesic

Behavioral effects of NOS inhibitor studied in rat model

3-D structure of MMP-2 published

New antitumor agents from Agouron acting as inhibitors of cyclin-dependent kinases

Taisho prepares new macrolide antibiotics active against sensitive and resistant bacteria

Selective alpha2-adrenoceptor antagonists developed at Pierre Fabre for neurodegenerative disorders

First launches announced for Asta Medica's LHRH antagonist

Ortho-McNeil presents basic research in the area of motilin antagonists

Protein kinase inhibitors from Glaxo for proliferative, metabolic and inflammatory disorders

Anticonvulsant isoquinoline series described in recent patent literature by SmithKline Beecham

Novel anticonvulsants designed by Howard University scientists

Novel rheumatic disease treatment strategy discussed at EULAR congress

Widely used antipsychotic drug under study for potential in RA

Interim results presented at EULAR from phase I trial of IDEC-131

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...
How to Summit up? Dis-Harmoni on ivonescimab NSCLC phase III
BioWorld
Wall Street pundits were divided about the likely fate of ivonescimab, Summit Therapeutics Inc.’s bispecific antibody partnered with Akeso Pharmaceuticals Inc.,...